Bristol Hospice

Bristol Hospice

Bristol Hospice is a family office headquartered in Salt Lake City, Utah, centered on the U.S. hospice industry. The firm's founding family has not publicly disclosed the origins of its wealth, but the office functions primarily as an operating platform for hospice care delivery. Bristol Hospice owns and operates numerous hospice facilities across multiple states, integrating investment management with direct healthcare operations. The firm's strategy combines direct ownership of hospice agencies with a disciplined acquisition model. It targets underperforming or independent hospices, standardizes clinical practices, and scales them under the Bristol brand. The asset-class mix is narrow—concentrated entirely in hospice and palliative care—with no disclosed exposure to equities, real estate, or alternative assets outside healthcare operations. Known transactions include acquisitions of regional hospice providers, though specific deal names are not publicly detailed. Geographically, the firm has a national footprint, with facilities concentrated in the Western and Southern United States. The scale of Bristol Hospice's investment portfolio is undisclosed, and the number of professionals leading the office is not publicly confirmed. The firm operates from a single known location in Salt Lake City, with no additional offices listed. No philanthropic foundations, operating subsidiaries outside hospice, or membership in investment clubs like Tiger 21 have been publicly tied to the office. One notable recent event: in 2023, Bristol Hospice expanded its presence in the Southeast through multiple acquisitions, per state licensing records and local press. Bristol Hospice's structural differentiator is its direct operational involvement: it is not a passive investment vehicle but an active hospice operator. The family office effectively functions as the corporate parent of a healthcare network, blurring the line between wealth management and business ownership. This model is relatively rare among family offices, most of which maintain arms-length investment portfolios rather than running operating companies.